Medicare Enrolled

Dr. Schuman Tam, M.D.

Optician · San Francisco, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
6850 GEARY BLVD, San Francisco, CA 94121
4157516800
In practice since 2006 (19 years)
NPI: 1184674400 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tam

Dr. Schuman Tam is an optician specialist in San Francisco, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tam performed 12,350 Medicare services across 1,245 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tam received a total of $23,047 from 43 pharmaceutical and/or device companies across 1022 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 7% volume in CA $23,047 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,350
Medicare services
Top 7% in CA for optician
1,245
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~650 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Allergy immunotherapy preparation
A professional service involving the preparation and administration of one or more antigens.
3,889 $15 $19
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
3,704 $4 $10
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
1,663 $11 $35
Allergy skin patch test
A diagnostic test where small amounts of potential allergens are applied to the skin to identify substances that cause an allergic reaction.
697 $5 $15
Allergen injection administration
Professional service for the administration of a single allergen injection.
626 $10 $27
Skin allergy test
A test where small amounts of potential allergens are injected into the skin to check for allergic reactions.
388 $8 $14
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
324 $109 $160
Airflow rate measurement test
A test that measures the rate of airflow. This procedure assesses how quickly air moves.
280 $37 $100
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
214 $12 $50
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
208 $75 $115
Allergy test using drug or biological combination
A diagnostic procedure to identify allergic reactions by testing a combination of methods using a specific drug or biological agent.
160 $18 $23
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
98 $91 $207
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
43 $129 $270
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
40 $50 $92
Allergy test using ingested items, initial 2 hours
This procedure involves testing for allergies by having the patient ingest specific items over an initial two-hour period.
16 $118 $165
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,047
Total received (2018-2024)
Avg $3,292/year across 7 years
Top 8% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
1,022
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,786 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$261 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,090
2023
$3,134
2022
$3,024
2021
$3,173
2020
$3,304
2019
$3,901
2018
$3,421

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$832
GlaxoSmithKline, LLC.
$537
GENZYME CORPORATION
$404
Takeda Pharmaceuticals U.S.A., Inc.
$282
PFIZER INC.
$164
Amgen Inc.
$125
Novartis Pharmaceuticals Corporation
$120
Genentech USA, Inc.
$101
CSL Behring
$89
Blueprint Medicines Corporation
$89
Optinose US, Inc.
$80
Octapharma USA, Inc.
$72
Regeneron Healthcare Solutions, Inc.
$69
Grifols USA, LLC
$56
Greer Laboratories, Inc.
$36
Invivyd Inc
$33
Top 3 companies account for 57.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$4,885
GlaxoSmithKline, LLC.
$4,433
GENZYME CORPORATION
$1,691
PFIZER INC.
$1,511
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,437
Genentech USA, Inc.
$1,244
Takeda Pharmaceuticals U.S.A., Inc.
$826
CSL Behring
$783
Octapharma USA, Inc.
$561
Teva Pharmaceuticals USA, Inc.
$561
Optinose US, Inc.
$475
OptiNose US, Inc.
$458
ALK-Abello, Inc
$432
Greer Laboratories, Inc.
$402
Regeneron Healthcare Solutions, Inc.
$333
Novartis Pharmaceuticals Corporation
$319
Grifols USA, LLC
$302
kaleo, Inc.
$276
Shire North American Group Inc
$257
AIMMUNE THERAPEUTICS, INC.
$218
Covis Pharma GmBH
$216
Amgen Inc.
$145
Blueprint Medicines Corporation
$126
Bio Products Laboratory USA, Inc.
$119
BioCryst US Sales Co., LLC
$103
Aimmune Therapeutics, Inc.
$98
LEO Pharma Inc.
$96
Circassia Pharmaceuticals Inc
$91
Covis Pharma B.V.
$86
Kaleo, Inc.
$84
Incyte Corporation
$78
SANOFI-AVENTIS U.S. LLC
$65
BioCryst Pharmaceuticals, Inc.
$54
ABBVIE INC.
$46
AbbVie Inc.
$42
Hikma Pharmaceuticals USA
$38
Invivyd Inc
$33
Covis Pharma GmbH
$27
NOVARTIS PHARMACEUTICALS CORPORATION
$27
Horizon Pharma plc
$25
Strongbridge US INC.
$17
Olympus America Inc.
$16
Circassia Inc.
$14
Top 3 companies account for 47.8% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · ADBRY · AIRSUPRA · ALVESCO · AUVI-Q · AYVAKIT · AirDuo Digihaler · AirDuo RespiClick · ArmonAir Digihaler · Auvi-Q · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CIBINQO · CINQAIR · CUTAQUIG · CUVITRU · DUPIXENT · ENT Fiberscopes · ESTRING · EUCRISA · FARXIGA · FASENRA · FIRAZYR · Gammaplex · Grastek · HYQVIA · Haegarda · Hizentra · KEVEYIS · Kloxxado · Mitigare · NIOX · NIOX VERO · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORALAIR · ORLADEYO · Odactra · Orladeyo · PALFORZIA · PANZYGA · PAXLOVID · PEMGARDA · Palforzia · Privigen · ProAir Digihaler · Prolastin-C Liquid · QVAR · RINVOQ · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · XOLAIR · Xembify · Xhance · Xofluza · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for optician in CA.

Looking for an optician specialist in San Francisco?
Compare opticians in the San Francisco area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
1,195
Per 100K population
142.9
County median income
$141,446
Nearest hospital
SAN FRANCISCO VA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tam is a mixed practice specialist, with above-average Medicare volume (top 7% in CA), with low-engagement industry engagement in the top 8% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Tam experienced with allergy immunotherapy preparation?
Based on Medicare claims data, Dr. Tam performed 3,889 allergy immunotherapy preparation services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tam receive payments from pharmaceutical companies?
Yes. Dr. Tam received a total of $23,047 from 43 companies across 1,022 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tam's costs compare to other opticians in San Francisco?
Dr. Tam's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →